Back to results
US 2026/0078437 A1Published application
Cell-free method of producing synthetic circular nucleic acid
AssigneeAldevron, LLC
InventorsNathan RUSSART, Venkata INDURTHI, Denis ARUTYUNOV
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a process of cell-free circular nucleic acid amplification using rolling circle amplification.
Claims28
A method of amplifying a synthetic circular nucleic acid, comprising:
- a) providing a circular nucleic acid template comprising:
- (i) a backbone, wherein the backbone comprises one or more endonuclease cut sites, and
- (ii) an insert sequence, wherein the insert sequence comprises one or more endonuclease cut sites on its 5′ and 3′ terminal ends;
- b) amplifying the circular nucleic acid template by rolling circle amplification, thereby producing an amplification product;
- c) contacting the amplification product with a first endonuclease under conditions for digestion, thereby producing a first digestion product;
- d) adding the first digestion product to a ligation reaction mixture comprising a ligase enzyme, wherein the first digestion product is added to the ligation reaction mixture gradually, continuously, or intermittently over time;
- e) incubating the ligation reaction mixture to produce a circular ligation product, wherein the circular ligation product is at least partially supercoiled;
- f) optionally contacting the circular ligation product with a topoisomerase enzyme under conditions suitable to promote supercoiling;
- g) contacting the circular ligation product with a first exonuclease that digests, linear nucleic acid, and open circle nucleic acid, thereby producing a final reaction product comprising synthetic circular nucleic acid that is substantially free of linear nucleic acid;
- and
- h) purifying the final reaction product by a purification method.
8 more elements
-8. (canceled)
(canceled)
(canceled)
(canceled)
-16. (canceled)
(canceled)
(canceled)
-25. (canceled)
A synthetic circular nucleic acid lacking (a) an origin of replication and/or a drug resistance gene and (b) a recombination site.
Dependencies are inferred from the claim text.